Publications by authors named "Debie Hoivik"

Claim this Profile
A
Assessing the Carcinogenicity of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, in Rodents.
Heather Kowalski, Debie Hoivik, Michael Rabinowitz

Toxicol Pathol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia.
Anna Zuk, Zhihai Si, Sally Loi, Santhosh Bommegowda, Debie Hoivik

J Pharmacol Exp Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigations of clofibrate in alternative carcinogenicity models.
Michael J Santostefano, Debie J Hoivik, Richard T Miller

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.
Carla E Torrey, James A Campbell, Debie J Hoivik, Richard T Miller, Jane S Allen

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.
Sarah R Nesfield, Christopher J Clarke, Debie J Hoivik, Richard T Miller, Jane S Allen

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.
Carla E Torrey, Henry G Wall, James A Campbell, Puntipa Kwanyuen, Debie J Hoivik

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
Carla E Torrey, Henry G Wall, James A Campbell, Puntipa Kwanyuen, Debie J Hoivik

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.
Sarah R Nesfield, Thomas C Williams, Debie J Hoivik, Richard T Miller, Jane S Allen

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.
Debie J Hoivik, Jane S Allen, Henry G Wall, James B Nold, Richard T Miller

Int J Toxicol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
Neal F Cariello, Elizabeth H Romach, Heidi M Colton, Hong Ni, Lawrence Yoon, Debie J Hoivik

Toxicol Sci· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.
Debie J Hoivik, Charles W Qualls, Rosanna C Mirabile, Neal F Cariello, Carie L Kimbrough

Carcinogenesis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP3A induction by N-hydroxyformamide tumor necrosis factor-alpha converting enzyme/matrix metalloproteinase inhibitors use of a pregname X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans.
Timothy K Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J Beaudet, Summer Jolley, Debie J Hoivik

Drug Metab Dispos· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis